Cormorant Asset Management’s Molecular Templates, Inc. MTEM Stock Holding History

Cormorant Asset Management’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,455	Closed	-$354K	–	66
2017 Q2	$354K	Hold	5,455	–	–	0.06%	67
2017 Q1	$513K	Sell	5,455 -680	-11%	-$63.6K	0.07%	69
2016 Q4	$446K	Hold	6,135	–	–	0.06%	71
2016 Q3	$686K	Hold	6,135	–	–	0.08%	73
2016 Q2	$643K	Buy	6,135 +74	+1%	+$5.3K	0.09%	73
2016 Q1	$460K	Hold	6,061	–	–	0.07%	77
2015 Q4	$480K	Buy	+6,061	New	+$2.99M	0.06%	77

Other funds holding MTEM

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cormorant Asset Management's MTEM Position: Q3 2017 in Review

Cormorant Asset Management sold out of Molecular Templates, Inc. (MTEM) in Q3 2017, closing a stake of 5,455 shares — an estimated $354K sold.

Cormorant Asset Management first reported a position in MTEM in Q4 2015 and held it in 7 quarters. The position peaked at $686K in Q3 2016. 29 funds tracked by Wall St. Rank hold MTEM as of Q3 2017.

Cormorant Asset Management reported no remaining Molecular Templates, Inc. position as of Q3 2017 after selling out during the quarter.
Cormorant Asset Management sold 5,455 Molecular Templates, Inc. shares in Q3 2017, an estimated $354K.
Cormorant Asset Management first reported a position in Molecular Templates, Inc. in Q4 2015 and held it in 7 quarters.
Cormorant Asset Management's Molecular Templates, Inc. position peaked at $686K in Q3 2016.
29 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2017.

Based on Cormorant Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.